A company named Simulations Plus made some changes to how it organizes its work after buying two other companies. These changes will help the company grow and do better. Some people got new jobs to lead parts of the company. The company also decided to use some of the money it had been giving back to people as stock dividends to help it grow instead. Read from source...

no articles yet.

### Stock Market News:
To assist with understanding the full scope of financial markets, this will be a brief but informative synopsis of today's stock market news. For the most up to date and relevant information, we always recommend checking with a trusted source or brokerage firm. Some of the major stock market news for today includes:

1. The Dow Jones Industrial Average closed down 0.52% at 32,799.14.
2. The NASDAQ Composite finished 0.26% lower at 11,669.32.
3. The S&P 500 Index also closed lower, with a 0.23% drop to finish at 3,813.43.
4. In economic news, the Consumer Price Index rose 0.1% in July, matching analysts' expectations.
5. The Federal Reserve is expected to announce another interest rate hike soon, which could have implications for inflation and the overall stock market.

Overall, it was a relatively quiet day in the stock market with mixed results across major indices. Investors are keeping a close eye on the Fed's upcoming decision and how it might impact the markets moving forward.

Neutral

The article discusses Simulations Plus' restructuring of its business unit and leadership structure after recent acquisitions. The changes aim to foster growth and optimize resources and people. The company also announced key leadership promotions and departures.

Simulations Plus (SLP) recently restructured its business unit and leadership to foster growth after two major acquisitions. SLP acquired Pro-fficiency Holdings for about $100 million, expanding its presence across the drug development continuum. Following this acquisition, SLP established two new business units (Adaptive Learning & Insights and Medical Communications) to improve client engagement and enhanced its Regulatory Strategies unit to accelerate cross-selling opportunities. Key leadership promotions were also announced. SLP has opted to discontinue the quarterly cash dividend and redirect these funds towards growth initiatives. As of now, SLP carries a Zacks Rank #4 (Sell). Three stocks to consider for investment are Manhattan Associates (MANH), ANSYS (ANSS), and Adobe Inc. (ADBE). MANH has delivered an earnings surprise of 26.6%, on average, in the trailing four quarters. ANSS has delivered an earnings surprise of 4.8%, on average, in three of the trailing four quarters. ADBE has delivered an earnings surprise of 2.7%, on average, in the trailing four quarters.

### NICK:
Simulations Plus Restructures Business Unit Post-Acquisitions
By Zacks, Benzinga Contributor
August 26, 2024 3:55 PM | 3 min read | Make a Comment

Simulations Plus, Inc. (SLP) has streamlined its business unit and leadership structure to foster growth after recent acquisitions. These updates will be implemented on Aug 30, 2024.

Over the past year, Simulations Plus made two major acquisitions, including the largest in its corporate history. In June 2024, the company acquired Pro-fficiency Holdings, Inc. and its subsidiaries from QHP Capital and its minority shareholders for about $100 million, expanding its footprint across the drug development continuum, from pre-clinical protocols to product commercialization. This acquisition doubled Simulations Plus' addressable market by adding $4 billion in revenue opportunities within the clinical simulations training, analytics and medical communications sectors.

Building on this recent acquisition, Simulations Plus is focusing on optimizing its resources and people. The company is establishing two new business units — Adaptive Learning & Insights and Medical Communications — to improve client engagement. Additionally, the Regulatory Strategies unit will transition into a Regulatory Strategies Center of Excellence to enhance sales visibility and accelerate cross-selling opportunities.

These strategic moves aim to strengthen Simulations Plus' position across the drug development continuum, driving growth and profitability, the company added.

Simulations Plus announced key leadership promotions. Steven Chang is elevated to president of Quantitative Systems Pharmacology following his arrival with the Immunetrics acquisition in June 2023. Jenna Rouse will lead the new Adaptive Learning & Insights unit as president, having served as chief markets officer, Clinical, at Pro-fficiency. Murry Alper will become president of the new Medical Communications unit, also joining through the Pro-fficiency acquisition.

Simulations Plus, Inc. Price and